For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Publishing research using ab226972? Please let us know so that we can cite the reference in this datasheet.
ab226972 has been referenced in 2 publications.
- Yu G et al. lncRNA TUG1 Promotes Cisplatin Resistance by Regulating CCND2 via Epigenetically Silencing miR-194-5p in Bladder Cancer. Mol Ther Nucleic Acids 16:257-271 (2019).
- He X et al. miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2). J Exp Clin Cancer Res 37:230 (2018).
Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact firstname.lastname@example.org